| Trial ID: | L0675 |
| Source ID: | NCT01510795
|
| Associated Drug: |
Spironolactone
|
| Title: |
Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: spironolactone
|
| Outcome Measures: |
Primary: Difference in 6-month changes in chronic Banff scores between spironolactone and retrospective control group, 6 months | Secondary: Difference in chronic Banff scores between spironolactone and retrospective control group at 12 months, eGFR at 6 and 12 months, urinary protein/creatinine ratio and urinary albumin/creatinine ratio at 6 and 12 months, 6-12 months
|
| Sponsor/Collaborators: |
Sponsor: Clinical Hospital Merkur
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2014-01
|
| Results First Posted: |
|
| Last Update Posted: |
2012-01-18
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01510795
|
